Concepedia

P. Schmid

PS

3

Publications

1.2K

Citations

3

H-Index

2018

Active since

Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center(Current)

University of California, San Francisco

Dana-Farber Cancer Institute

Queen Mary University of London

Aichi Cancer Center

P. Schmid is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in cancer therapeutics, oncology, and radiation oncology.

Top concepts

Publications per year

2018–2022

3

Publications

3

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Sylvia Adams, P. Schmid, H. S. Rugo et al. · Annals of Oncology · 2018 · 756 citations · Full text

First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis

Leisha A. Emens, Sylvia Adams, Carlos H. Barrios et al. · Annals of Oncology · 2021 · 437 citations · Full text

LBA76 Overall survival (OS) results from the phase III TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physician's choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC)

Hope S. Rugo, A. Bardia, F. Marmé et al. · Annals of Oncology · 2022 · 55 citations · Full text

, , +4

Rows per page

1–3 of 3